Today's Low | Today's High | |
---|---|---|
276.45 276.80 |
| 296.00 296.00 |
52 Week Low | 52 Week High | |
---|---|---|
133.00 (04-Jun-2024) 132.75 (04-Jun-2024) |
| 296.00 (10-Dec-2024) 296.00 (10-Dec-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
0 | 50,757 |
Bid Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Ask Price | Quantity |
---|---|
292.24 | 50,757.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 50,757 |
Market Cap: | ₹45.31 Cr |
PE Ratio (TTM): | -118.70 |
PB Ratio: | 1.13 |
Industry P/E: | 0.00 |
Debt to Equity: | - |
ROE: | -0.95 |
EPS (TTM): | -2.46 |
Book Value: | 221.39 |
Face Value: | 2.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 59.72 Cr | 69.55 Cr | 113.13 Cr | 78.40 Cr | 106.54 Cr |
Profit | -5.78 Cr | -21.33 Cr | -10.23 Cr | -6.54 Cr | -17.28 Cr |
Expense | 104.64 Cr | 117.02 Cr | 147.26 Cr | 99.15 Cr | 154.21 Cr |
Comprehensive income | -3.45 Cr | -15.08 Cr | -18.56 Cr | -24.96 Cr | -35.15 Cr |
EPS | -0.37 | -1.36 | -0.65 | -0.42 | -1.10 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Dishman Carbogen Amcis Limited | Sep, 2017 Sep, 2017 | Pharmaceuticals Pharmaceuticals | DCAL DCAL |
Promoters | |
---|---|
59.32% |
Public | |
---|---|
40.68% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
59.32% |
Public | |
---|---|
40.68% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
59.32% |
Public | |
---|---|
40.68% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
59.32% |
Public | |
---|---|
40.68% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
59.32% |
Public | |
---|---|
40.68% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 276.45 on the NSE (National Stock Exchange) to a maximum of 296.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 276.80 to a high of 296.00.
The stock's performance over the past 52 weeks reveals a low of 133.00 (occurred on 04-Jun-2024) and a high of 296.00 (achieved on 10-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 132.75 (on 04-Jun-2024), and the 52-week high is 296.00 (on 10-Dec-2024).
The stock's performance over the past 52 weeks reveals a low of 133.00 (occurred on 04-Jun-2024) and a high of 296.00 (achieved on 10-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 132.75 (on 04-Jun-2024), and the 52-week high is 296.00 (on 10-Dec-2024).
The total volume is 49, and the total traded value is 139.66 (₹ Lakhs).
The upper circuit limit is 332.04, and the lower circuit limit is 221.36.
The market cap is ₹45.31 Cr, and the PE ratio (TTM) is 0.00.
The PB ratio is 1.31, industry P/E is 0.00 .
ROE is -0.95, EPS is -2.46, book value is 221.39
In Sep 2023, Revenue is ₹597200000.00, and Profit is ₹-57800000.00. In Jun 2023, Revenue is ₹695500000.00, and Profit is ₹-213300000.00.
The company, Dishman Carbogen Amcis Limited, was listed in Sep 2017 and belongs to the Pharmaceuticals industry. Its NSE symbol is DCAL.
As of latest available update, promoters hold 59.32%, the public holds 40.68%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.